Trial Profile
Special population study of intranasal testosterone in subjects with allergis rhinitis
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 May 2012
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Pharmacokinetics; Registrational
- Acronyms AA-DD
- 01 May 2012 Final results are expected by the end of quarter two 2012 as reported by Trimel Pharmaceutical Corporation.
- 01 May 2012 New trial record